DW

Doug Ward

Lumos Diagnostics Holdings Limited | Chief Executive Officer, Managing Director
Mr Ward has more than 30 years of biotech and medical technology experience at global healthcare companies including Roche, GE, Siemens, Bayer, Chiron and Hologic. During his career, Mr Ward has held executive positions where he developed and implemented novel business strategies and introduced transformational products to the practice of medicine. Prior to joining Lumos, he served as Vice President, Strategy and Business Development at Hologic where he led a global team responsible for fostering innovation in womens healthcare to improve clinical results. Mr Ward also served as the CEO of Personal Genome Diagnostics (PGDx). He brings experience across all company functions, including Commercial Leadership, R&D, Operations, Quality, Regulatory, Service, and Support.

Company and Roles

Company
Title
Tenure
Since
LDX
LDX
Lumos Diagnostics Holdings Limited
  • Chief Executive Officer
  • Managing Director
4yrs, 3mthJun 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
LDX
LDX
Lumos Diagnostics Holdings Limited
27/08/262,743,0008,348,08320,595,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
LDX
LDX
Lumos Diagnostics Holdings Limited
27/08/26
Transfer
8,348,083$0.100$834,808Off-market transfer
LDX
LDX
Lumos Diagnostics Holdings Limited
27/08/26
Transfer
8,348,083$0.100$834,808Off-market transfer
LDX
LDX
Lumos Diagnostics Holdings Limited
27/08/26
Buy
202,131$0.105$21,223On-market trade
LDX
LDX
Lumos Diagnostics Holdings Limited
24/07/26
Exercise
6,000,000$0.110$660,000Conversion of securities
LDX
LDX
Lumos Diagnostics Holdings Limited
24/07/26
Issued
4,166,752$0.110$458,342Conversion of securities